Biomatrix for upper and lower airway biomarkers in patients with allergic asthma - 17/09/18
Doi : 10.1016/j.jaci.2018.07.027
Ulrich M. Zissler, PhD a 
, Moritz Ulrich a, b, Constanze A. Jakwerth, PhD a, Sandra Rothkirch, MD a, b, Ferdinand Guerth, MEng a, Markus Weckmann, PhD c, Matthias Schiemann, PhD d, Bernhard Haller, PhD e, Carsten B. Schmidt-Weber, PhD a, Adam M. Chaker, MD a, b
, Moritz Ulrich a, b, Constanze A. Jakwerth, PhD a, Sandra Rothkirch, MD a, b, Ferdinand Guerth, MEng a, Markus Weckmann, PhD c, Matthias Schiemann, PhD d, Bernhard Haller, PhD e, Carsten B. Schmidt-Weber, PhD a, Adam M. Chaker, MD a, b a Center of Allergy & Environment (ZAUM), Technical University of Munich and Helmholtz Center Munich, German Research Center for Environmental Health, Germany, Member of the German Center for Lung Research (DZL), CPC-M, Munich, Germany
b Department of Otorhinolaryngology and Head and Neck Surgery, Medical School, Technical University of Munich, Munich, Germany
c Department of Pediatric Allergy and Pulmonology, Children's Hospital at the University of Luebeck, Luebeck, Germany, and Member of the German Center for Lung Research (DZL), Airway Research Center North (ARCN)
d Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
e Institut für Medizinische Statistik und Epidemiologie, Medical School, Technical University of Munich, Munich, Germany
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 17 September 2018
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Supported by the German Center for Lung Research (DZL). |
|
| Disclosure of potential conflict of interest: U.M.Z. received payment for manuscripts from Deutsches Aerzteblatt and funds for travel from the European Academy of Allergy and Clinical Immunology (EAACI) and Collegium Internationale Allergologicum (CIA). C.B.S.-W. received support for research projects from PLS Design, LETI, Zeller AG, and Allergopharma and accepted honoraria for consultancy and seminars from LETI and Allergopharma. A.M.C. has consultant arrangements through Technical University Munich with Allergopharma, ALK-Abelló, HAL Allergy, Mundipharma, and Lofarma; has conducted clinical studies and received research grants through Technical University Munich from Allergopharma, Novartis, the German Federal Environmental Agency, Bencard/Allergen Therapeutics, ASIT Biotech, and Zeller AG; has received payment for lectures from Allergopharma, ALK-Abelló, and GlaxoSmithKline; has received payment for manuscript preparation from Bayerisches Ärzteblatt; and has received travel support from the European Academy of Allergy and Clinical Immunology, DGAKI, and SMI. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?